Skip to content

Study · Not a test of the peptide alone · 1990

3 results

[Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].

Franchuk AE, Benzar ZT

Akusherstvo i ginekologiia1 Sept 1990

PMID2278306 (opens in a new tab)PepBankPUB-02278306
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with postabortal endometritis, thymalin and T-activin modulated quantitative and qualitative lymphocyte characteristics.

    In plain wordsIn patients with postabortal endometritis, thymalin and T-activin changed lymphocyte characteristics.

    Peptide
    Thymalin
    Outcome
    Direction not reportedLymphocyte characteristics
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    These drugs were found to have immunomodulating effects on quantitative and qualitative characteristics of T- and B-lymphocytes and their subpopulations and on phagocytic function of polynuclears.
    1 context sentence
    Summary · context
    The immune status has been assessed in 73 patients with postabortal endometritis and thymalin and T-activin have been evaluated as an intervention for secondary immunodeficiency associated with this condition.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with postabortal endometritis, thymalin and T-activin modulated polynuclear phagocytic function.

    In plain wordsIn patients with postabortal endometritis, thymalin and T-activin changed immune-cell phagocytic function.

    Peptide
    Thymalin
    Outcome
    Direction not reportedPolynuclear phagocytic function
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    These drugs were found to have immunomodulating effects on quantitative and qualitative characteristics of T- and B-lymphocytes and their subpopulations and on phagocytic function of polynuclears.
    1 context sentence
    Summary · context
    The immune status has been assessed in 73 patients with postabortal endometritis and thymalin and T-activin have been evaluated as an intervention for secondary immunodeficiency associated with this condition.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with postabortal endometritis, comprehensive therapy using thymalin and T-activin improved management efficacy.

    In plain wordsIn patients with postabortal endometritis, comprehensive therapy using thymalin and T-activin improved treatment efficacy.

    Peptide
    Thymalin
    Outcome
    IncreaseTreatment efficacy
    Study

    n: not reported in source

    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    Comprehensive therapy using thymalin and T-activin improves the efficacy of management of postabortal endometritis.
    1 context sentence
    Summary · context
    The immune status has been assessed in 73 patients with postabortal endometritis and thymalin and T-activin have been evaluated as an intervention for secondary immunodeficiency associated with this condition.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.